The Latest in Lupus & Connective Tissue Diseases

‘Unheard of’ PAH improvement with novel drug: STELLAR

March 13, 2023

Lupus & Connective Tissue Diseases

Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis

March 8, 2023

Lupus & Connective Tissue Diseases

FDA approves first biologic treatment for polymyalgia rheumatica

March 1, 2023

Autoantibodies signal reduced cancer risk in dermatomyositis

February 22, 2023

Lupus & Connective Tissue Diseases

How to recognize and treat hidden inflammation

February 21, 2023

Lupus & Connective Tissue Diseases

New tool better estimates cardiovascular risk in people with lupus

February 16, 2023

Lupus & Connective Tissue Diseases

Health plans get very poor scores for access to autoimmune drugs

February 14, 2023

Two biomarkers identify high-risk lupus nephritis

February 14, 2023

Lupus & Connective Tissue Diseases

Systemic sclerosis antibodies show link to interstitial lung disease in RA

February 6, 2023

75 years: A look back on the fascinating history of methotrexate and folate antagonists

January 26, 2023

Topical CBD oil study suggests benefits for pain, healing in systemic sclerosis digital ulcers

January 25, 2023

Lupus & Connective Tissue Diseases

VEXAS syndrome: More common, variable, and severe than expected

January 24, 2023

Lupus & Connective Tissue Diseases

Teamwork guides cardio-rheumatology clinics that care for unique patient population

January 23, 2023

Best estimates made for hydroxychloroquine retinopathy risk

January 18, 2023

Belimumab for pregnant women with lupus: B-cell concerns remain

January 17, 2023

Lupus & Connective Tissue Diseases